04:59 PM EDT, 03/25/2026 (MT Newswires) -- FibroBiologics ( FBLG ) said late Wednesday that its board has approved a 1-for-20 reverse stock split of its shares to help regain compliance with Nasdaq's minimum bid price requirement

Trading on a split-adjusted basis will begin on March 30, it said.

The reverse stock split will reduce the number of shares to about 3.5 million from about 70.3 million, the company said.